Divergent synthesis of biflavonoids yields novel inhibitors of the aggregation of amyloid β (1–42)

TH Sum, TJ Sum, S Collins, WRJD Galloway… - Organic & …, 2017 - pubs.rsc.org
Biflavonoids are associated with a variety of biologically useful properties. However,
synthetic biflavonoids are poorly explored within drug discovery. There is considerable …

Gelatin as a potential inhibitor of insulin amyloid fibril formation

J Jayamani, G Shanmugam - ChemistrySelect, 2016 - Wiley Online Library
Direct inhibition of amyloid fibrillation, the primary cause of many neurodegenerative
diseases, using natural and synthetic molecules is one of the therapeutic strategies to …

[引用][C] 双黄酮类化合物药理作用研究

缪刘萍, 王鑫杰, 周海凤, 吴彤 - 世界临床药物, 2012

Kolaflavanone, a biflavonoid derived from medicinal plant Garcinia, is an inhibitor of mitotic kinesin Eg5

IMD Alrazi, TH Ogunwa, AO Kolawole… - The Journal of …, 2021 - academic.oup.com
Mitotic kinesin Eg5 remains a validated target in antimitotic therapy because of its essential
role in the formation and maintenance of bipolar mitotic spindles. Although numerous Eg5 …

Structural features of small molecule amyloid-beta self-assembly inhibitors

B Torok, S Bag, M Sarkar, S Dasgupta… - Current Bioactive …, 2013 - ingentaconnect.com
The role of various structural features, namely basic scaffolds and substituents of small
molecule inhibitors of the self-assembly of amyloid-beta (Aβ) peptide, a key process in …

Inhibition of β-amyloid Aggregation of Ugni molinae Extracts

D Jara-Moreno, AL Riveros, A Barriga… - Current …, 2020 - ingentaconnect.com
The β-amyloid peptide (1-42) is a molecule capable of aggregating into neurotoxic
structures that have been implicated as potential etiological factors of Alzheimer's Disease …

Development of a brain-permeable peptide nanofiber that prevents aggregation of Alzheimer pathogenic proteins

N Tanaka, M Okuda, T Nishigaki, N Tsuchiya… - PLOS …, 2020 - journals.plos.org
Alzheimer's disease (AD) is proposed to be induced by abnormal aggregation of amyloidβ in
the brain. Here, we designed a brain-permeable peptide nanofiber drug from a fragment of …

Modeling of chemical inhibition from amyloid protein aggregation kinetics

JA Vázquez - BMC Pharmacology and Toxicology, 2014 - Springer
Backgrounds The process of amyloid proteins aggregation causes several human
neuropathologies. In some cases, eg. fibrillar deposits of insulin, the problems are …

[引用][C] 穗花杉双黄酮的生物活性研究进展

张震, 王峰 - 中国新药杂志, 2013

Dehydroabietylamine derivatives as multifunctional agents for the treatment of Alzheimer's disease

Y Cao, L Wang, Z Lin, F Liang, Z Pei, J Xu, Q Gu - MedChemComm, 2014 - pubs.rsc.org
Dehydroabietylamine derivatives have been reported to eliminate the superoxide anion
(O2−˙) and 1, 1-dipheny-2-picrylhydrazyl radicals. In this work, several dehydroabietylamine …